Piceatannol

Piceatannol

SCHEMBL29754702

Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 6/20 1.00
TP53 P04637 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP3A4 P08684 3/20 1.00
CYP2C9 P11712 3/20 1.00
HIF1A Q16665 3/20 1.00
HSD17B10 Q99714 3/20 1.00
KDM4E B2RXH2 3/20 1.00
MEN1 O00255 3/20 1.00
ALDH1A1 P00352 3/20 1.00
LMNA P02545 3/20 1.00
MAPT P10636 3/20 1.00
HPGD P15428 3/20 1.00
KMT2A Q03164 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
TTR P02766 3/20 1.00
ALOX5 P09917 3/20 1.00
ALOX12 P18054 2/20 1.00
PKM P14618 2/20 1.00
ALOX15 P16050 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piceatannol SCHEMBL29929133 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL29501290 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL43541 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL19953785 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL505561 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL15026144 0.95 LCK (0.91) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL1932873 0.95 LCK (0.91) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL31706727 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL1824175 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL30631591 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN claimed
EP-4313010-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 Szekeres, Thomas (AT) 2024-02-07 EP claimed
WO-2022200086-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 SZEKERES THOMAS (AT) 2022-09-29 WO claimed
EP-4734923-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS L'OREAL (FR) 2026-05-06 EP disclosed
WO-2025006412-A1 CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS L'OREAL (FR) 2025-01-02 WO disclosed
WO-2024249297-A2 POLYMERIC COMPOSITIONS WITH PRENYLATED STILBENES Cambium Biomaterials, Inc. (US) 2024-12-05 WO disclosed
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN disclosed
EP-4440531-A1 KIT AND METHOD FOR TREATING SKIN L'OREAL (FR) 2024-10-09 EP disclosed
EP-4422760-A1 COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF RETINOL L'OREAL (FR) 2024-09-04 EP disclosed
EP-4422579-A1 COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL L'OREAL (FR) 2024-09-04 EP disclosed
CN-118354749-A Kit and method for treating skin 莱雅公司 2024-07-16 CN disclosed
EP-4171486-A1 COSMETIC COMPOSITION PROVIDING UNIQUE SENSORIAL SENSATIONS L'OREAL (FR) 2023-05-03 EP disclosed
EP-4171487-A1 COSMETIC COMPOSITION FOR IMPROVED PENETRATION L'OREAL (FR) 2023-05-03 EP disclosed
EP-4171476-A1 COSMETIC COMPOSITIONS HAVING STABILIZED RETINOL L'OREAL (FR) 2023-05-03 EP disclosed
CN-115996697-A Cosmetic composition with improved penetration 莱雅公司 2023-04-21 CN disclosed
CN-115884751-A Cosmetic composition providing unique sensory feel 莱雅公司 2023-03-31 CN disclosed
CN-115867250-A Skin tightening cosmetic compositions and methods of use 莱雅公司 2023-03-28 CN disclosed
WO-2023278511-A1 COSMETIC COMPOSITION CONTAINING A RHEOLOGICAL-MODIFYING AND STABILIZING POLYMER BLEND L'OREAL (FR) 2023-01-05 WO disclosed
WO-2022200086-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 SZEKERES THOMAS (AT) 2022-09-29 WO disclosed
CN-114796470-A Resveratrol compound and CAR-T cell targeting NKG2D ligand combined preparation of medicine for treating malignant tumor 深圳宾德生物技术有限公司 2022-07-29 CN disclosed